Literature DB >> 24954208

Polo-like kinases: structural variations lead to multiple functions.

Sihem Zitouni1, Catarina Nabais1, Swadhin Chandra Jana1, Adán Guerrero2, Mónica Bettencourt-Dias1.   

Abstract

Members of the polo-like kinase (PLK) family are crucial regulators of cell cycle progression, centriole duplication, mitosis, cytokinesis and the DNA damage response. PLKs undergo major changes in abundance, activity, localization and structure at different stages of the cell cycle. They interact with other proteins in a tightly controlled spatiotemporal manner as part of a network that coordinates key cell cycle events. Their essential roles are highlighted by the fact that alterations in PLK function are associated with cancers and other diseases. Recent knowledge gained from PLK crystal structures, evolution and interacting molecules offers important insights into the mechanisms that underlie their regulation and activity, and suggests novel functions unrelated to cell cycle control for this family of kinases.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24954208     DOI: 10.1038/nrm3819

Source DB:  PubMed          Journal:  Nat Rev Mol Cell Biol        ISSN: 1471-0072            Impact factor:   94.444


  205 in total

Review 1.  The primary cilium: keeper of the key to cell division.

Authors:  Junmin Pan; William Snell
Journal:  Cell       Date:  2007-06-29       Impact factor: 41.582

2.  Cdc28-dependent regulation of the Cdc5/Polo kinase.

Authors:  Eric M Mortensen; Wilhelm Haas; Melanie Gygi; Steven P Gygi; Douglas R Kellogg
Journal:  Curr Biol       Date:  2005-11-22       Impact factor: 10.834

3.  Absence of polo-like kinase 3 in mice stabilizes Cdc25A after DNA damage but is not sufficient to produce tumors.

Authors:  David L Myer; Susan B Robbins; Moying Yin; Gregory P Boivin; Yang Liu; Kenneth D Greis; El Mustapha Bahassi; Peter J Stambrook
Journal:  Mutat Res       Date:  2011-03-03       Impact factor: 2.433

Review 4.  Polo-box domain: a versatile mediator of polo-like kinase function.

Authors:  Jung-Eun Park; Nak-Kyun Soung; Yoshikazu Johmura; Young H Kang; Chenzhong Liao; Kyung H Lee; Chi Hoon Park; Marc C Nicklaus; Kyung S Lee
Journal:  Cell Mol Life Sci       Date:  2010-02-11       Impact factor: 9.261

5.  Mitotic effects of a constitutively active mutant of the Xenopus polo-like kinase Plx1.

Authors:  Y W Qian; E Erikson; J L Maller
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

6.  Mammalian Polo-like kinase 3 (Plk3) is a multifunctional protein involved in stress response pathways.

Authors:  El Mustapha Bahassi; Christopher W Conn; David L Myer; Robert F Hennigan; Clare H McGowan; Yolanda Sanchez; Peter J Stambrook
Journal:  Oncogene       Date:  2002-09-26       Impact factor: 9.867

7.  Polo-like kinase 4 autodestructs by generating its Slimb-binding phosphodegron.

Authors:  Joseph E Klebba; Daniel W Buster; Annie L Nguyen; Stephen Swatkoski; Marjan Gucek; Nasser M Rusan; Gregory C Rogers
Journal:  Curr Biol       Date:  2013-10-31       Impact factor: 10.834

8.  Components of the Hippo pathway cooperate with Nek2 kinase to regulate centrosome disjunction.

Authors:  Balca R Mardin; Cornelia Lange; Joanne E Baxter; Tara Hardy; Sebastian R Scholz; Andrew M Fry; Elmar Schiebel
Journal:  Nat Cell Biol       Date:  2010-11-14       Impact factor: 28.824

9.  Antibody microinjection reveals an essential role for human polo-like kinase 1 (Plk1) in the functional maturation of mitotic centrosomes.

Authors:  H A Lane; E A Nigg
Journal:  J Cell Biol       Date:  1996-12       Impact factor: 10.539

10.  Overexpressing centriole-replication proteins in vivo induces centriole overduplication and de novo formation.

Authors:  Nina Peel; Naomi R Stevens; Renata Basto; Jordan W Raff
Journal:  Curr Biol       Date:  2007-05-03       Impact factor: 10.834

View more
  186 in total

Review 1.  Recent Advances and New Strategies in Targeting Plk1 for Anticancer Therapy.

Authors:  Kyung S Lee; Terrence R Burke; Jung-Eun Park; Jeong K Bang; Eunhye Lee
Journal:  Trends Pharmacol Sci       Date:  2015-10-17       Impact factor: 14.819

2.  The methyltransferase SETD6 regulates Mitotic progression through PLK1 methylation.

Authors:  Michal Feldman; Zlata Vershinin; Inna Goliand; Natalie Elia; Dan Levy
Journal:  Proc Natl Acad Sci U S A       Date:  2019-01-08       Impact factor: 11.205

3.  PLK1 Inhibition Targets Myc-Activated Malignant Glioma Cells Irrespective of Mismatch Repair Deficiency-Mediated Acquired Resistance to Temozolomide.

Authors:  Fumi Higuchi; Alexandria L Fink; Juri Kiyokawa; Julie J Miller; Mara V A Koerner; Daniel P Cahill; Hiroaki Wakimoto
Journal:  Mol Cancer Ther       Date:  2018-09-14       Impact factor: 6.261

4.  Miz1 Controls Schwann Cell Proliferation via H3K36me2 Demethylase Kdm8 to Prevent Peripheral Nerve Demyelination.

Authors:  David Fuhrmann; Marco Mernberger; Andrea Nist; Thorsten Stiewe; Hans-Peter Elsässer
Journal:  J Neurosci       Date:  2017-12-07       Impact factor: 6.167

5.  Mutual regulation between Polo-like kinase 3 and SIAH2 E3 ubiquitin ligase defines a regulatory network that fine-tunes the cellular response to hypoxia and nickel.

Authors:  Cen Li; Soyoung Park; Xiaowen Zhang; Wei Dai; Dazhong Xu
Journal:  J Biol Chem       Date:  2017-05-17       Impact factor: 5.157

6.  O-GlcNAcylation of myosin phosphatase targeting subunit 1 (MYPT1) dictates timely disjunction of centrosomes.

Authors:  Caifei Liu; Yingxin Shi; Jie Li; Xuewen Liu; Zhikai Xiahou; Zhongping Tan; Xing Chen; Jing Li
Journal:  J Biol Chem       Date:  2020-04-15       Impact factor: 5.157

7.  Targeting PLK1 overcomes T-DM1 resistance via CDK1-dependent phosphorylation and inactivation of Bcl-2/xL in HER2-positive breast cancer.

Authors:  Özge Saatci; Simone Borgoni; Özge Akbulut; Selvi Durmuş; Umar Raza; Erol Eyüpoğlu; Can Alkan; Aytekin Akyol; Özgür Kütük; Stefan Wiemann; Özgür Şahin
Journal:  Oncogene       Date:  2018-02-02       Impact factor: 9.867

Review 8.  Playing polo during mitosis: PLK1 takes the lead.

Authors:  G Combes; I Alharbi; L G Braga; S Elowe
Journal:  Oncogene       Date:  2017-04-24       Impact factor: 9.867

Review 9.  The role of Plk3 in oncogenesis.

Authors:  C Helmke; S Becker; K Strebhardt
Journal:  Oncogene       Date:  2015-04-27       Impact factor: 9.867

10.  Integrated Genomic and Proteomic Analyses Reveal Novel Mechanisms of the Methyltransferase SETD2 in Renal Cell Carcinoma Development.

Authors:  Lin Li; Weili Miao; Ming Huang; Preston Williams; Yinsheng Wang
Journal:  Mol Cell Proteomics       Date:  2018-11-28       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.